Literature DB >> 90396

alpha 2-Antiplasmin consumption and fibrinogen breakdown during thrombolytic therapy.

D Collen, M Verstraete.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 90396     DOI: 10.1016/0049-3848(79)90118-x

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  5 in total

Review 1.  Postoperative changes in hemostasis analyzed by the serial determination of fibrinopeptides and D-dimer.

Authors:  J Kang; J Kambayashi; M Sakon; T Tsujinaka; T Mori
Journal:  Jpn J Surg       Date:  1989-05

Review 2.  Anisoylated plasminogen streptokinase activator complex (APSAC). A review of its mechanism of action, clinical pharmacology and therapeutic use in acute myocardial infarction.

Authors:  J P Monk; R C Heel
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

3.  Release of alpha 2-plasmin inhibitor from plasma fibrin clots by activated coagulation factor XIII. Its effect on fibrinolysis.

Authors:  J Mimuro; S Kimura; N Aoki
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

4.  Alpha2-Antiplasmin: The Devil You Don't Know in Cerebrovascular and Cardiovascular Disease.

Authors:  Satish Singh; Sofiyan Saleem; Guy L Reed
Journal:  Front Cardiovasc Med       Date:  2020-12-23

5.  Application of a plasmin generation assay to define pharmacodynamic effects of tranexamic acid in women undergoing cesarean delivery.

Authors:  Adam Miszta; Homa K Ahmadzia; Naomi L C Luban; Shuhui Li; Dong Guo; Lori A Holle; Jeffrey S Berger; Andra H James; Jogarao V S Gobburu; John van den Anker; Bas de Laat; Alisa S Wolberg
Journal:  J Thromb Haemost       Date:  2020-12-26       Impact factor: 5.824

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.